APOE and Alzheimer disease: Therefore, our purpose was to construct a database of [11C]-PiB PET scans from cognitively normal, non-APOE ε4 carriers with negative cerebrospinal fluid (CSF) biomarkers for AD and to use SPM on a test cohort of cognitively normal subjects with variable AD risk factors.